Related Experiment Video
Updated: Oct 18, 2025

Author Spotlight: Impact of Intergenic Interactions on Disease-Identifying Dark Biomarkers
Published on: March 1, 2024
lncRNA THAP7-AS1, transcriptionally activated by SP1 and post-transcriptionally stabilized by METTL3-mediated m6A
Hai-Ting Liu1,2, Yong-Xin Zou1, Wen-Jie Zhu1
1Key Laboratory for Experimental Teratology of the Ministry of Education and Department of Pathology, School of Basic Medical Sciences, Cheeloo College of Medicine, Shandong University, Jinan, P.R. China.
Abstract:
Long noncoding RNAs (lncRNAs) are dysregulated in different cancer types, and thus have emerged as important regulators of the initiation and progression of human cancers. However, the biological functions and the underlying mechanisms responsible for their functions in gastric cancer (GC) remain poorly understood. Here, by lncRNA microarray, we identified 1414 differentially expressed lncRNAs, among which THAP7-AS1 was significantly upregulated in GC tissues compared with non-tumorous gastric tissues. High expression of THAP7-AS1 was correlated with positive lymph node metastasis and poorer prognosis. SP1, a transcription factor, could bind directly to the THAP7-AS1 promoter region and activate its transcription. Moreover, the m6A modification of THAP7-AS1 by METTL3 enhanced its expression depending on the "reader" protein IGF2BP1-dependent pathway. THAP7-AS1 promoted GC cell progression. Mechanistically, THAP7-AS1 interacted with the 1-50 Amino Acid Region (nuclear localization signal) of CUL4B through its 1-442 nt Sequence, and it promoted interaction between nuclear localization signal (NLS) and importin α1, and improved the CUL4B protein entry into the nucleus, repressing miR-22-3p and miR-320a expression by CUL4B-catalyzed H2AK119ub1 and the EZH2-mediated H3K27me3, subsequently activating PI3K/AKT signaling pathway to promote GC progression. Moreover, LV-sh-THAP7-AS1 treatment could suppress GC growth, invasion and metastasis, indicating that THAP7-AS1 may act as a promising molecular target for GC therapies. Taken together, our results show that THAP7-AS1, transcriptionally activated by SP1 and then modified by METTL3-mediated m6A, exerts oncogenic functions, by promoting interaction between NLS and importin α1 and then improving the CUL4B protein entry into the nucleus to repress the transcription of miR-22-3p and miR-320a.
Insights
This study reveals THAP7-AS1, a long noncoding RNA, promotes gastric cancer (GC) progression by enhancing CUL4B nuclear entry. Targeting THAP7-AS1 offers a potential therapeutic strategy for GC.
Area of Science:
- Oncology
- Molecular Biology
- Epigenetics
Background:
- Long noncoding RNAs (lncRNAs) are implicated in cancer, but their roles in gastric cancer (GC) are not fully understood.
- Identifying novel molecular regulators is crucial for developing effective GC therapies.
Purpose of the Study:
- To elucidate the function and mechanism of THAP7-AS1 in gastric cancer.
- To investigate THAP7-AS1 as a potential therapeutic target for GC.
Main Methods:
- lncRNA microarray analysis to identify differentially expressed lncRNAs in GC.
- Investigation of transcriptional regulation by SP1 and m6A modification by METTL3.
- Functional assays to assess the impact of THAP7-AS1 on GC cell progression and metastasis.
- Mechanism studies involving protein-RNA interactions, nuclear import, and downstream signaling pathways.
Main Results:
- THAP7-AS1 was significantly upregulated in GC tissues and correlated with poor prognosis and lymph node metastasis.
- SP1 transcriptionally activated THAP7-AS1, while METTL3-mediated m6A modification enhanced its expression.
- THAP7-AS1 promoted GC cell progression by facilitating CUL4B nuclear entry, leading to repression of miR-22-3p and miR-320a, and activation of the PI3K/AKT pathway.
- Inhibition of THAP7-AS1 suppressed GC growth, invasion, and metastasis.
Conclusions:
- THAP7-AS1 acts as an oncogene in gastric cancer through a novel mechanism involving CUL4B nuclear translocation.
- THAP7-AS1 is a promising molecular target for GC therapy.
Related Concept Videos
lncRNA - Long Non-coding RNAs
Abnormal Proliferation
Induced Pluripotent Stem Cells
Somatic...
Master Transcription Regulators
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Regulation of Nuclear Protein Sorting

